Abstract
The efficacy of IgG infusion therapy in ITP is now established even in cases resistant to other forms of therapy. However, the mechanism of action is still speculative. We assume that a correction of the elevated thrombocyte clearance is brought about at several levels. First, antibodies specific for an inciting antigen (and for which the patient is deficient) may remove free antigen and/or immune complexes which adhere to platelet surfaces, thereby rendering platelets less susceptible to clearance. Second, IgG may act nonspecifically by protecting the platelet surface from becoming covered with immune complexes. Third, monomeric IgG may display a nonspecific inhibitory effect at the level of the interaction of immunologically altered platelets with Fc receptors of mononuclear phagocytes. For the latter effect, good in vivo evidence exists. However, it must be born in mind that interaction of antibodies with Fc receptors is but one mechanisms for triggering adherence and endocytosis. A variety of other receptors and binding sites exists which may interact with immunologically altered thrombocytes. These may either trigger phagocytes on their own or facilitate the interaction of antibodies and Fc receptors. How IgG infusion infl...Continue Reading
References
Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·J K CzopK F Austen
Aug 1, 1977·Annals of Internal Medicine
Nov 1, 1979·Journal of Clinical Pathology·I A BakerJ R O'Brien
Jan 18, 1979·The New England Journal of Medicine·D B Cines, A D Schreiber
Feb 1, 1977·The Journal of Experimental Medicine·A G Ehlenberger, V Nussenzweig
Jun 11, 1975·The Journal of Experimental Medicine·C BiancoS C Silverstein
Jul 1, 1968·Experimental Cell Research·I Gigli, R A Nelson
Jun 6, 1981·Lancet·P ImbachH P Wagner
Jan 15, 1983·Lancet·A C NewlandA H Waters
Feb 19, 1983·Lancet·B Rowbotham, R L Brearley
Jan 1, 1981·The Journal of Experimental Medicine·M P BevilacquaC Bianco
Jan 1, 1984·The Journal of Clinical Investigation·N DanaM A Arnaout
Feb 1, 1983·British Journal of Haematology·B GrossU E Nydegger
Apr 1, 1983·JAMA : the Journal of the American Medical Association·R R CarrollC S Kitchens
Jun 1, 1984·Blut·C Mueller-EckhardtC Förster
Mar 1, 1983·Blut·P Imbach, T W Jungi
Aug 1, 1983·Blut·T AbeM Kazama
Oct 1, 1983·The Journal of Pediatrics·J B BusselS Barandun
May 27, 1982·The New England Journal of Medicine·J FehrU Kappeler
Jan 1, 1981·Medical and Pediatric Oncology·P ImbachH P Wagner
May 15, 1982·Thrombosis Research·G FolleaM Dechavanne
Oct 1, 1981·British Journal of Haematology·S L PfuellerD Tew
Sep 1, 1981·American Journal of Hematology·W KayserR E Schmidt
Citations
Jul 4, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·H YamadaS Fujimoto
Feb 1, 1986·Blut·E HillerH Riess
Feb 1, 1988·Blut·B ImholzH P Wagner
Jan 1, 1986·International Journal of Cell Cloning·J A Zaia
Jan 1, 1987·Clinical and Laboratory Haematology·R M Minchinton, K McGrath
Jul 1, 1991·DICP : the Annals of Pharmacotherapy·C J Wordell